The available clinical data are discordant with regard to PD-L1 expression in EGFR-mutated NSCLC,93,94 with two meta-analyses failing to confirm a positive correlation with EGFR mutations, probably for differences in the types of specimens analyzed and in the PD-L1 testing.95 Here, EGFR is linked to non-small cell lung carcinoma.